Industry News
Biotechnology Industry News

UPDATE: Pfizer and Trillium: How a $25M investment led to a $2.3B buyout
UPDATE: Pfizer and Trillium: How a $25M investment led to a $2.3B buyout ntaylor Tue, 09/14/2021 - 07:54
Another death blights Astellas’ $3B Audentes buy as FDA slaps clinical hold on the test
Another death blights Astellas' $3B Audentes buy as FDA slaps clinical hold on the test badams Tue, 09/14/2021 - 03:37
Kapeller’s Rome bags $77M to strike gold in the backwaters of the genome
Kapeller's Rome bags $77M to strike gold in the backwaters of the genome ntaylor Mon, 09/13/2021 - 11:40
Provention will wait for FDA to ‘opine’ on new data after teplizumab rejection, eyes Q4 for further talks
Provention will wait for FDA to 'opine' on new data after teplizumab rejection, eyes Q4 for further talks badams Mon, 09/13/2021 - 09:37
Attacking Alzheimer’s by blocking ‘frustrated’ amyloid proteins before they form plaques
Attacking Alzheimer's by blocking 'frustrated' amyloid proteins before they form plaques arlene.weintraub Mon, 09/13/2021 - 09:18
4 years after leaving Prime time, Rusty Williams lands a new job leading school of Walking Fish
4 years after leaving Prime time, Rusty Williams lands a new job leading school of Walking Fish badams Mon, 09/13/2021 - 09:04
AbbVie bets $370M on pivotal eye disease gene therapy, puts up $1.4B in biobucks
AbbVie bets $370M on pivotal eye disease gene therapy, puts up $1.4B in biobucks ntaylor Mon, 09/13/2021 - 08:26
Everest bags COVID-19 program in bid to conquer Chinese mRNA market
Everest bags COVID-19 program in bid to conquer Chinese mRNA market ntaylor Mon, 09/13/2021 - 05:21
Ixaka’s cell therapy clears early phase 3 data review
Ixaka’s cell therapy clears early phase 3 data review ntaylor Fri, 09/10/2021 - 08:35
Vor’s cancer cell therapy gets on FDA fast track ahead of 2022 data drop
Vor’s cancer cell therapy gets on FDA fast track ahead of 2022 data drop ntaylor Fri, 09/10/2021 - 06:10
Researchers pinpoint autoimmune antibodies that may predict COVID-19 severity
Researchers pinpoint autoimmune antibodies that may predict COVID-19 severity klahucik Thu, 09/09/2021 - 15:37
Cardiff reveals early data on challenger to Amgen’s KRAS crown
Cardiff reveals early data on challenger to Amgen's KRAS crown aarmstrong Thu, 09/09/2021 - 10:20
Obsidian bags $115M to untether cell therapy from toxic sidekick
Obsidian bags $115M to untether cell therapy from toxic sidekick ntaylor Thu, 09/09/2021 - 06:54
Lilly-backed Lycia Therapeutics nabs $70M round for its protein degradation tech
Lilly-backed Lycia Therapeutics nabs $70M round for its protein degradation tech badams Thu, 09/09/2021 - 06:49
Sanofi’s BTK inhibitor flunks phase 3 autoimmune trial, delivering blow to $3.7B biotech bet
Sanofi's BTK inhibitor flunks phase 3 autoimmune trial, delivering blow to $3.7B biotech bet ntaylor Thu, 09/09/2021 - 05:21
FDA slams the door in Humanigen’s face, rejects emergency use green light, wants more data
FDA slams the door in Humanigen’s face, rejects emergency use green light, wants more data badams Thu, 09/09/2021 - 05:20
Science 37 teams up with Roche’s Foundation Medicine to boost home-based oncology trials
Science 37 teams up with Roche’s Foundation Medicine to boost home-based oncology trials badams Thu, 09/09/2021 - 04:48
As gene therapy safety faces scrutiny, Broad Institute proposes a safer and more efficient delivery tool
As gene therapy safety faces scrutiny, Broad Institute proposes a safer and more efficient delivery tool aliu Wed, 09/08/2021 - 13:41
Lexeo keeps foot on the gas pedal with $100M financing to follow up Stelios buy
Lexeo keeps foot on the gas pedal with $100M financing to follow up Stelios buy aarmstrong Wed, 09/08/2021 - 13:07
BioNTech reports promising data on mRNA cocktail in mouse models of colon cancer and melanoma
BioNTech reports promising data on mRNA cocktail in mouse models of colon cancer and melanoma arlene.weintraub Wed, 09/08/2021 - 11:14

